0 Комментарии
0 Поделились
130 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Influenza Therapeutics Market Trends: Advancements in Broad-Spectrum Antiviral Drugs and BiologicsThe influenza therapeutics market is witnessing steady expansion as seasonal outbreaks, pandemic preparedness initiatives, and advancements in antiviral drug development continue to shape global healthcare priorities. According to industry estimates, the Influenza Therapeutics Market size is projected to grow from US$ 6.95 billion in 2025 to US$ 10.10 billion by 2034, registering a CAGR of...0 Комментарии 0 Поделились 508 Просмотры 0 предпросмотр
-
The Race Against Viruses: What’s Driving Innovation in Antiviral Drugs market?According to the latest report published by Data Bridge Market Research, the Antiviral Drugs Market CAGR Value The global antiviral drugs market size was valued at USD 78.12 billion in 2024 and is expected to reach USD 119.78 billion by 2032, at a CAGR of 5.5% during the forecast period An influential Antiviral Drugs Market document comprises of a detailed analysis of...0 Комментарии 0 Поделились 305 Просмотры 0 предпросмотр
-
What Are the Latest Trends in Europe Antiviral Drugs Market for Infectious Disease Treatment?Europe Antiviral Drugs Market Summary: According to the latest report published by Data Bridge Market Research, the Europe Antiviral Drugs Market CAGR Value Data Bridge Market Research analyzes that the Europe antiviral drugs market is expected to reach the value of USD 22,549.32 million by 2030, with a CAGR of 5.3% during the forecast period. Europe Antiviral Drugs Market is the...0 Комментарии 0 Поделились 395 Просмотры 0 предпросмотр
-
Liver Medicine Market to Grow at 10.9% CAGR Through 2034Liver medicine refers to pharmaceutical therapies, biologics, and preventive solutions designed to manage, treat, or prevent disorders affecting liver function. These therapies address viral infections, metabolic disorders, inflammatory conditions, and liver malignancies. Continuous advancements in clinical research are strengthening treatment outcomes and expanding therapeutic possibilities....0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
RdRp Inhibitor Market to Reach USD 521.68 Million by 2028 | CAGR 8.2%According to a newly published market research report by 24LifeSciences, global RdRp inhibitor market was valued at USD 352.14 million in 2023 and is projected to reach USD 521.68 million by 2028, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2024-2028. RNA-dependent RNA polymerase (RdRp) inhibitors represent a critical antiviral therapy class that prevents...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Respiratory Tract Infection Treatment Market to Reach USD 13.5 Billion by 2031 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global respiratory tract infection treatment market was valued at USD 9.8 billion in 2024 and is projected to reach USD 13.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 20252031. Respiratory tract infections (RTIs) remain among the most common infectious diseases...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Respiratory Tract Infection Treatment Market to Reach USD 13.5 Billion by 2031 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global respiratory tract infection treatment market was valued at USD 9.8 billion in 2024 and is projected to reach USD 13.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 20252031. Respiratory tract infections (RTIs) remain among the most common infectious diseases...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
The Hepatitis B Therapeutics Market is expected to reach US$ 7.26 billion by 2031, registering a CAGR of 8.8% from 2025 to 2031.Hepatitis B therapeutics refer to the drugs and treatments used to manage and control hepatitis B virus infection. These therapies aim to reduce viral replication and prevent liver damage. Common treatments include antiviral medications that help improve long-term outcomes. Hepatitis B Therapeutics Market Overview The Hepatitis B Therapeutics Market is projected to reach US$ 7.26...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр1
-
Viral Conjunctivitis Drugs Market Growth Drivers and InsightsViral conjunctivitis drugs are specifically designed to treat highly contagious eye infections triggered by viral pathogens. These medications help control inflammation, reduce irritation, and alleviate discomfort associated with red and watery eyes. Their timely use not only supports faster symptom relief but also helps minimize transmission within communities. Market Overview The global Viral...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
Расширенные страницы